Dolby Laboratories (NYSE:DLB) Updates FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 4.300-4.450 for the period, compared to the consensus earnings per share estimate of 4.110. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q3 2026 guidance to 0.560-0.710 EPS.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, January 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research report on Monday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Stock Performance

Shares of NYSE DLB traded down $6.66 during midday trading on Friday, reaching $57.48. The company’s stock had a trading volume of 2,131,257 shares, compared to its average volume of 737,788. The business’s 50 day moving average price is $62.58 and its two-hundred day moving average price is $64.55. The company has a market cap of $5.49 billion, a P/E ratio of 23.18 and a beta of 0.86. Dolby Laboratories has a fifty-two week low of $55.73 and a fifty-two week high of $78.28.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.07. The business had revenue of $346.71 million for the quarter, compared to analysts’ expectations of $341.26 million. Dolby Laboratories had a net margin of 17.97% and a return on equity of 11.50%. The firm’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same period last year, the firm posted $1.14 earnings per share. Sell-side analysts forecast that Dolby Laboratories will post 3.17 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio (DPR) is 58.06%.

Insider Buying and Selling

In related news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $66.14, for a total value of $198,420.00. Following the transaction, the senior vice president directly owned 83,218 shares of the company’s stock, valued at $5,504,038.52. This trade represents a 3.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Ryan Nicholson sold 2,667 shares of Dolby Laboratories stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $66.38, for a total transaction of $177,035.46. Following the completion of the transaction, the chief accounting officer directly owned 36,956 shares in the company, valued at $2,453,139.28. This trade represents a 6.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 37.93% of the company’s stock.

More Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Q2 results showed revenue growth driven by licensing strength, broadcast demand and wider Dolby Atmos adoption; Dolby topped estimates on the quarter. Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y
• Positive Sentiment: Management raised FY?2026 EPS guidance to a range above consensus (FY EPS 4.30–4.45), suggesting confidence in full?year profitability despite near?term headwinds. Dolby Laboratories Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Board declared a quarterly cash dividend of $0.36 per share (yield ~2.5%), returning capital to shareholders and supporting income investors.
• Neutral Sentiment: Earnings call transcript and supplemental materials are available for details on product wins, licensing cadence and customer momentum — useful for investors who want to parse the drivers behind the beats and guidance. Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Wall Street coverage remains generally constructive with a small number of buy/outperform ratings and price targets above current levels; this provides analyst support but hasn’t prevented the near?term selloff. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings
• Negative Sentiment: Q3 guidance was well below consensus (Q3 EPS 0.56–0.71 vs. est. ~0.92; revenue guide ~$295–325M vs. est. ~$343M), which is the main driver of the stock decline as investors re?price near?term growth expectations. Dolby Laboratories Reports Second Quarter 2026 Financial Results
• Negative Sentiment: Reported softness in operating cash flow and a year?over?year decline in cash balances, plus notable insider selling and some institutional position reductions, add to near?term investor caution. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings
• Negative Sentiment: Despite the beats, the market reaction was a selloff as investors focused on the weak near?term guide and metric details rather than the full?year raise. Dolby Laboratories (NYSE:DLB) Surprises With Q1 CY2026 Sales But Stock Drops

Institutional Trading of Dolby Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp grew its stake in shares of Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock worth $167,906,000 after buying an additional 180,072 shares during the last quarter. First Trust Advisors LP grew its stake in shares of Dolby Laboratories by 23.8% during the fourth quarter. First Trust Advisors LP now owns 1,880,528 shares of the electronics maker’s stock worth $120,768,000 after buying an additional 361,871 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the last quarter. Snyder Capital Management L P grew its stake in shares of Dolby Laboratories by 24.4% during the fourth quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock worth $91,648,000 after buying an additional 279,743 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Dolby Laboratories by 7.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,237,572 shares of the electronics maker’s stock worth $79,482,000 after buying an additional 87,645 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.